Showing results (91-100 of 205) with videos related to

Sort By:
Pageof 21
Malaria Journal|August 13, 2016
Plasma levels of Galectin-9 reflect disease severity in malaria infectionBindongo P P Dembele, Haorile Chagan-Yasutan, Toshiro Niki, et al.
Biomedicines|January 21, 2022
Galectin-9 Triggers Neutrophil-Mediated Anticancer ImmunityNatasha Ustyanovska Avtenyuk, Ghizlane Choukrani, Emanuele Ammatuna, et al.
Clinical Journal of Gastroenterology|May 29, 2019
Neuroendocrine carcinoma of the esophagus with an adenocarcinoma componentYuki Kaneko, Shin Saito, Kazuya Takahashi, et al.
International Journal of Molecular Sciences|June 29, 2017
Secretion of IFN-γ Associated with Galectin-9 Production by Pleural Fluid Cells from a Patient with Extrapulmonary TuberculosisJingge Zhao, Beata Shiratori, Haorile Chagan-Yasutan, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|November 25, 2014
Preserved or enhanced OATP1B3 expression in hepatocellular adenoma subtypes with nuclear accumulation of β-cateninToshio Fukusato, Yurie Soejima, Fukuo Kondo, et al.
European Journal of Immunology|November 20, 2012
HCV-infected hepatocytes drive CD4+ CD25+ Foxp3+ regulatory T-cell development through the Tim-3/Gal-9 pathwayXiao J Ji, Cheng J Ma, Jia M Wang, et al.
American Journal of Respiratory and Critical Care Medicine|May 13, 2011
Galectin-9 attenuates acute lung injury by expanding CD14- plasmacytoid dendritic cell-like macrophagesKeisuke Kojima, Tomohiro Arikawa, Naoki Saita, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Pazopanib Confers a Progression-free Survival in a Patient with Ewing's Sarcoma/Primitive Neuroectodermal Tumor of the LungAyako Takigami, Hideaki Yamasawa, Ayako Kurosaki, et al.
Oncology Reports|December 10, 2013
The HSP90 inhibitor 17-N-allylamino-17-demethoxy geldanamycin (17-AAG) synergizes with cisplatin and induces apoptosis in cisplatin-resistant esophageal squamous cell carcinoma cell lines via the Akt/XIAP pathwayTakashi Ui, Kazue Morishima, Shin Saito, et al.
Cancer Science|April 12, 2007
Hypoxia increases the motility of lung adenocarcinoma cell line A549 via activation of the epidermal growth factor receptor pathwayTao Wang, Toshiro Niki, Akiteru Goto, et al.
Pageof 21